AzTrials
AzTrials

ObesityNCT05792657

The ABEL Feasibility Study (Adherence, Better Health, Exercise and Life Satisfaction)

A study testing High dosage in-person exercise coaching, Medium dosage in-person exercise coaching. and Low dosage in-person exercise coaching in people with Obesity, run by Norges idrettshøgskole at 1 site in Norway.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The ambition of the ABEL feasibility study is to test new "green prescription" follow-up models that can get more women with obesity, regularly active, with improved health and physical fitness. Read more about this study

Who is it for?
Ages 18 to 65 years, women onlyHealthy volunteers can take part
Conditions the study is for
Obesity
What is being tested?
High dosage in-person exercise coaching, Medium dosage in-person exercise coaching. and Low dosage in-person exercise coaching
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteNorway
Study dates
26 Jan 2023to 26 Jun 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age between 18 to 65 years
  • No fitness club membership six months prior to recruitment
  • Low-active (<150 minutes of moderate-intensity or 75 minutes of vigorous-intensity per week)
  • Norwegian speaking
  • In possession of a mobile phone.

Who cannot join

  • Chronic disease or pathology (e.g severe hypertension 180/110 mm Hg), heart disease or lung disease hindering exercise
  • Changing GP during the intervention
  • Functional impairment due to injuries hindering physical activity and exercise.

Trial locations and contacts

1 site in 1 country.

Tron Krosshaug, PhD contact

+4745660046

Tronk@nih.no

Elene M Tangen, Msc contact

+4795787210

Elene.tangen@gmail.com

Norway1 site, 1 recruiting

  • Norwegian School of Sport Sciences

    Oslo, 0806

    Tron Krosshaug, PhD, +47 23 26 23 49, tronk@nih.no

    Recruiting

Other trials in Norway

About this study

Official title: The ABEL Feasibility Study (Adherence, Better Health, Exercise and Life Satisfaction): A Randomized Controlled Trial

The ambition of the ABEL feasibility study is to test new "green prescription" follow-up models that can get more women with obesity, regularly active, with improved health and physical fitness. The project will evaluate the effect on exercise behavior, total physical activity level and mental and physical health outcomes by four different follow-up models by an exercise professional: HIGH-dosage in-person exercise coaching (four session monthly), MEDIUM- dosage in-person exercise coaching (two sessions monthly) LOW-dosage in-person exercise coaching (one session monthly). The main aim of this study is to evaluate which of these follow-up models is most effective on improving women's exercise adherence, total physical activity level, physical fitness, and mental and physical health. This will be weighed against the cost of each of the follow-up models, in order to identify the best model from a socioeconomic cost-effectiveness perspective. Moreover, the study will identify potential barriers among patients, General Practitioners and exercise professionals that prevents optimal outcome from the current green prescription model.

Read the detailed description

BACKGROUND:

Obesity, defined as "abnormal or excessive fat accumulation that presents a risk to health" and a body mass index (BMI) of ≥30, represents a major health challenge and economic burden for welfare systems worldwide. Living with obesity is reported to account for 80-85% of the risk of developing non-communicable diseases such as diabetes type 2. Guidance on regular physical activity, exercise and healthy eating is traditionally the first measure taken for patient who undergo treatment for obesity. Treatment for obesity in the primary healthcare service is largely coordinated by general practitioners (GP). Green prescriptions (tailored advice and guidance on lifestyle factors related to development of disease, such as physical activity and healthy eating) can be prescribed as a treatment alternative to patients with chronic disease, such as obesity. However, few GPs in Norway use green prescriptions as a treatment alternative to their patients, and 41% of GPs in 2006 reported that they had newer prescribed green prescriptions to their patients. The lack of sufficient follow-up of patients has been reported as a main limitation with the current green prescription model.

Previous research underlines the importance in-person coaching for patients who receives green prescriptions, as well as establishing collaborations with professions such as exercise professionals to be able to provide sufficient coaching of patients. Hence, in-person coaching by an exercise professional may have the means to get more patients with obesity regularly active, and can potentially be the follow-up alternative the current green prescription model is lacking.

However, considering the expenses and practical considerations associated with in-person coaching, has former studies displayed the advantage of using web-based behavioral support for patients with obesity. Yet, web-based behavioral support often proves to have poor completion rate, and need to be combined with face-to-face guidance and feedback in order to increase adherence. However, when combining in-person coaching and web-based behavioral support, there is still limited knowledge on how frequent in-person coaching needs to occur, in order to increase adherence. More knowledge on frequency of follow-up is essential for an approach towards an economical sustainable green prescription model.

AIMS:

  1. In women with obesity (BMI≥30), what is the effect of in-person exercise coaching (high vs. medium vs. low dosage) on exercise adherence and total physical activity level?
  2. In women with obesity (BMI≥30), what is the effect of in-person exercise coaching (high vs. medium vs. low dosage) on mental health variables (quality of life, self-efficacy and barriers and motivation to exercise)?
  3. In women with obesity (BMI≥30), what is the effect of in-person exercise coaching (high vs. medium vs. low dosage) on health (glycated hemoglobin, cholesterol, blood pressure, waist circumference, BMI and urinary incontinence) and physical fitness (aerobic endurance, muscular strength)?
  4. Is adherence to exercise and succeeding health effects associated with the exercise professionals level of education and knowledge base?
  5. What are the participant's experiences, barriers and facilitators of participating in the ABEL-project?
  6. What are the general practitioners' experiences, barriers and facilitators of using the "green prescription"?

STUDY DESIGN AND METHOD:

In the present feasibility study, women with obesity (BMI of ≥30, n=200) will be recruited to a 20-week randomized control trial (RCT) with four arms. Participants will be recruited via social media platforms (Facebook and Instagram). Using simple computer-based randomization program, participants will be randomized to one of the following arms: HIGH dosage in person exercise coaching, MEDIUM dosage in-person exercise coaching, LOW dosage in-person exercise coaching, and CONTROL group. A total of 25 exercise professionals, working full time as a personal trainer will follow up the participants at one of the following fitness clubs: "Feel24", "PT-group", "Nr1 Fitness", "Trento" or "Spenst". All participants in the intervention arms (HIGH, MEDIUM and LOW) groups are provided the same frequency (each week) of follow-up by the exercise professional. At baseline, all participants will respond to an electronic questionnaire, perform measures of muscular strength and aerobic endurance, measure blood pressure, hip-waist ratio, BMI (height and weight) and take a blood sample (Tigeni Kit). After a 20-weeks intervention period, participants will perform a post-test including the same previous mentioned outcome measures.

n=15 of women from intervention arms HIGH (n=5), MEDIUM (n=5) and LOW (n=5), will also be invited to participate in an in-depth interview in order to investigate participants experiences and barriers for participating in the ABEL feasibility study.

In addition to the RCT, the project will also recruit GPs (n=8) to participate in an in-depth interview with researchers from the project group. GPs will be recruited to provide more in-depth understanding on reasons for what the current green prescription model is lacking.

Conditions
Obesity
Being tested
High dosage in-person exercise coaching, Medium dosage in-person exercise coaching., Low dosage in-person exercise coaching
Keywords
Exercise is medicine, Exercise adherence, Total physical activity level, Exercise professionals, Women with obesity (>30 BMI)
Medical subject headings
Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • High dosage in-person exercise coachingBehavioural

    High dosage (one hour each week) of in-person exercise coaching by an exercise professional.

  • Medium dosage in-person exercise coaching.Behavioural

    Medium dosage (one hour every other week) of in-person exercise coaching by an exercise professional.

  • Low dosage in-person exercise coachingBehavioural

    Low dosage (one hour every month) of in-person exercise coaching by an exercise professional

Study groups in NCT05792657
Study groupRoleWhat they receive
HIGH dosage in-person exercise coachingExperimentalOne in-person exercise session with an exercise professional/weekly. A total of 20 hours of in-person coaching during the 20 weeks of intervention.
Receives: Behavioral: High dosage in-person exercise coaching
MEDIUM dosage in-person exercise coachingExperimentalTwo in-person exercise session with an exercise professional/monthly, and 15 minutes web-based behavioral support on the non-supervised weeks.A total of 10 hours in-person coaching during the 20 weeks intervention.
Receives: Behavioral: Medium dosage in-person exercise coaching.
LOW dosage in-person exercise coachingExperimentalOne in-person exercise session with the exercise professional/monthly, and 15 minutes web-based behavioral support on the non-supervised weeks.Total of five hours of in-person coaching during the 20 weeks intervention.
Receives: Behavioral: Low dosage in-person exercise coaching
CONTROLNo interventionWill be asked to continuing with normal life, and will receive regular follow-up care from their GP. This group will be giving the "Norwegian Directorate of Health's" recommendations for physical activity and nutrition, and will have access to the ABEL-app in order to register physical activity and exercise, but will not be provided any coaching during the 20 weeks.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Adherence (attendance) to prescribed exercise sessions

    Measures of adherence to exercise sessions will be collected through the ABEL-app (ABEL Technologies). Sessions performed with the exercise professional will be logged through the ABEL-app of the exercise professional, while sessions performed independently will be logged through the ABEL-app of the participant. Participants adherence will be measured by attendance (percentage of exercise sessions completed out of exercise sessions offered).

    Measured: Continuously during the intervention period of 20 weeks

Secondary outcomes (23)

  1. Fulfillment of physical activity recommendations

    To determine whether participants are meeting the physical activity recommendations, a single question whil be asked : "for the last six months, have you participated in more or less than 150 minutes of moderate physical activity each week?" Participants can respond either "more" or "less", where more is greater than less. Fulfillment of physical activity recommendations, exercise frequency, duration of exercise sessions and physical activity mode will be combined in order to measure participants physical activity behavior.

    Measured: At baseline and following the intervention period (20 weeks)

  2. Exercise frequency

    Exercise frequency will be measured by a single questions: "how often do you exercise each week?" participants can give a respond from 0-"7, where 7 is greater than 0. Exercise frequency, fulfillment of physical activity recommendations, duration of exercise sessions and mode of physical activity will be combined in order to measure participants physical activity behavior.

    Measured: At baseline and following the intervention (20 weeks).

  3. Duration of exercise sessions

    Duration of exercise sessions will be measured by a single question: "how long do you usually exercise per session? Participants can give a respond in minutes from "below 30 minutes" to "above 90 minutes", where above 90 minutes is greater than 30 minutes. Duration of exercise sessions, fulfillment of physical activity recommendations, mode of physical activity and frequency of exercise sessions will be combined in order to measure participants physical activity behavior.

    Measured: At baseline and following the intervention period (20 weeks)

  4. Mode of physical activity

    To determine which type of physical activity participants performs, participants will answer a single question: "Which of the following types of activities do you usually participate in? Participants are able to select more than one response of: "Commuting activities", "activities at home", "cycling", "walking", "exercising at a fitness club", "home exercises", and "exercising in sports". Mode of physical activity, fulfillment of physical activity recommendations, exercise frequency and exercise durations will be combined to measure participants physical activity behavior.

    Measured: At baseline and following the intervention period (20 weeks)

  5. Health-related quality of life

    Will be measured by a Norwegian version of "The MOS 36-item short-form health survey" (SF-36). The SF-36 has eight scaled scores; the scores are weighted sums of the questions in each section. Scores range from 0-100. Lower scores = more disability, higher scores = less disability.

    Measured: At baseline and following the intervention period (20 weeks)

  6. Self-efficacy

    Will be measured by a Norwegian abbreviated validated version of a "Self-Efficacy Survey" consisting of 12 statements. The subscale covers four to eight statements where the participants rated each statement on a five-point scale, where 5 is the highest grade of self-efficacy, and 1 is the lowest. For each subscale, a sum score (from 1 to 5) will be calculated by adding scores from each statement, divided by the number of statements.

    Measured: at baseline and following the intervention period (20 weeks)

  7. Motivation for exercise and physical activity

    Will be measured by a Norwegian version of the validated survey "BREQ-2", which measures the levels of self-determination in motivation for exercise and physical activity on a 5-point Likert-scale (from 1 to 5). Score range from 0-100, where high scores means more intrinsic motivated for exercise and physical activity.

    Measured: At baseline and following the intervention period (20 weeks)

  8. Perceived social support from family and friends

    Questions to measure social support for exercise and physical activity will be based on a validated social support questionnaire consisting of 13 statements concerning social support from friends and family. The participants rate each statement on how often, on a five-point scale, their family or friends have been supportive of them exercising. A total social support score will be calculated (from 6 to 30), where higher scores demonstrated greater social support for exercise and physical activity.

    Measured: At baseline and following the intervention period (20 weeks)

  9. Stage of motivational readiness for exercise and physical activity

    Will be measured in line with a previously conducted questionnaire on exercise professionals effect on changing attitude towards physical activity and exercise. Participants will rate one statement (on how likely they are to start exercising the next six months) according to the five stages in the stages of change model: re-contemplation (not intending to make changes), Contemplation (considering a change), Preparation (getting ready to make a change), Action (actively engaged in making a change but only for a short while) \& Maintenance (sustaining the change over time). "Maintenance" is the highest grade of motivation, followed by "Action", "Preparation" and "Contemplation". "Re-contemplation" is the lowest grade of motivation.

    Measured: At baseline and following the intervention period (20 weeks)

  10. Barriers to exercise

    Questions will be based on barriers previously identified among a Norwegian adult population (n= 12 504) and among fitness club members. 18 barriers will be included in the questionary. The participants rated how limiting they perceived each barrier to be on a three-point scale (1= not correct, 3=very correct). By adding the score from each barrier divided by the number of statements, a sum-score (from 1 to 3) for each subscale will be calculated.

    Measured: At baseline and following the intervention period (20 weeks)

  11. Urinary incontinence

    Will be measured using a Norwegian version of the "Incontinence Questionaire-Short Form (ICIQ-UI SF)". Measures will be given by a Likert scale from "never" to "all the time". Awareness and knowledge about pelvis floor muscles exercises will be assessed by single questions: "Do you do pelvic floor muscle exercises?" If yes, how many times weekly?" "If yes, has your exercise professional provided you any coaching on pelvic floor muscle exercises?"

    Measured: At baseline and following the intervention period (20 weeks)

  12. Glycated hemoglobin

    Will be collected through capillary blood drawn from finger pricks by Tigeni self testing kits. Measures will be given in mmol/L

    Measured: At baseline and following the intervention period (20 weeks)

  13. Blood pressure

    Will be assessed by the participants GP. Both systolic and diastolic blood pressure will be measured. Unit of measures is millimeters of mercury (mmHg).

    Measured: At baseline and following the intervention period (20 weeks)

  14. Weight

    Will be measured by the participants GP. Unit of measures is in kilogram (kg). Weight and height will be combined to report BMI in kg/m2

    Measured: At baseline and following the intervention period (20 weeks)

  15. Height

    Will be measured by the participants GP. Unit of measures is centimeters (cm). Weight and height will be combined to report BMI in kg/m2

    Measured: At baseline and following the intervention period (20 weeks)

  16. Cholesterol

    Cholesterol will be collected through capillary blood drawn from finger pricks by Tigeni self testing kits. Unit of measures is mmol/L

    Measured: At baseline and following the intervention period (20 weeks)

  17. Heart rate recovery

    Unit of measures is beats per minute (BPM). Heart rate recovery combined with RPE and working heart rate will be used to assess relative changes in participants aerobic endurance.

    Measured: At baseline and following the intervention period (20 weeks)

  18. The Borg Rating of Perceived Exertion (RPE)

    Measures will be given on a rating scale from 6 (no exertion) to 20 (maximal exertion). Participants will perform a standardized incline treadmill-walking test. RPE, heart rate recovery and changes in working heart rate will be combined to assess participants relative changes in aerobic endurance.

    Measured: At baseline and following the intervention period (20 weeks)

  19. Working heart rate

    Unit of measures is beats per minute (BPM). Working heart rate is combined with RPE and Heart rate recovery to assess participants relative changes in aerobic endurance.

    Measured: At baseline and following the intervention period (20 weeks)

  20. Muscular strength

    Will be assessed by a 1-RM (repetition maximum) estimation test in: chest press, close grip lat pull down and leg press. Load will progressively be increase until the participant reaches nine or less repetitions. Brzycki 1-RM prediction equation will be used to estimate the 1-RM based on the resistance and repetitions performed. The equation is mathematically expressed as 1RM = W/ [102.78- 2.78(R)]/100, where W is the weight used and R is the maximal number of repetitions performed.

    Measured: At baseline and following the intervention period (20 weeks)

  21. Factors associated with exercise adherence and drop-out

    n=15 of participants from the intervention group: HIGH, MEDIUM and LOW will be invited to participate in a semi-structured in-depth interview. A former investigation in Norway, including 14 questions designed to address factors associated with exercise adherence and drop-out. These questions will be combined with questions covering BPNES in order to measure participant's experiences, barriers and facilitators of participating in the study.

    Measured: Following the intervention period (20 weeks)

  22. Basic physicological needs in exercise (BPNES)

    n=15 of participants from the intervention group: HIGH, MEDIUM and LOW. Will be invited to participate in a semi-structured in-depth interview including questions covering fulfillment of BPNES (autonomy, relatedness and competence). Questions regarding fulfilment of BPNES will be combined with questions designed to address factors associated with exercise adherence and drop-out, to evaluate participant's experiences, barriers and facilitators of participating in the study.

    Measured: Following the intervention period (20 weeks)

  23. In-depth interview (general practitioners)

    n=8 general practitioners will participate in a semi-structured in-depth interview (approximately 45 min). The interview will be led by researchers from the project group, audiotaped and transcribed verbatim. Questions will be based on a previous qualitative study conducted on GPs in Norway, covering GPs experiences with the current green prescription model, and views on exercise as medicine.

    Measured: Following the intervention period (20 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Mar 2023
  2. Study start26 Jan 2023
  3. Primary completion26 Jun 2023 (estimated)
  4. Study completion26 Jun 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Factorial
Masking
None (open label)
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05792657
Sponsor's protocol ID
EMT2023
Status last verified
Feb 2023
First submitted
10 Feb 2023
Last updated
31 Mar 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • O'Regan A, Pollock M, D'Sa S, Niranjan V. ABC of prescribing exercise as medicine: a narrative review of the experiences of general practitioners and patients. BMJ Open Sport Exerc Med. 2021 Jun 2;7(2):e001050. doi: 10.1136/bmjsem-2021-001050. eCollection 2021.

    PubMed 34150320

  • Elley CR, Garrett S, Rose SB, O'Dea D, Lawton BA, Moyes SA, Dowell AC. Cost-effectiveness of exercise on prescription with telephone support among women in general practice over 2 years. Br J Sports Med. 2011 Dec;45(15):1223-9. doi: 10.1136/bjsm.2010.072439. Epub 2010 Nov 16.

    PubMed 21081641

  • Ries AL, Kaplan RM, Myers R, Prewitt LM. Maintenance after pulmonary rehabilitation in chronic lung disease: a randomized trial. Am J Respir Crit Care Med. 2003 Mar 15;167(6):880-8. doi: 10.1164/rccm.200204-318OC. Epub 2002 Dec 27.

    PubMed 12505859

  • Powell-Wiley TM, Poirier P, Burke LE, Despres JP, Gordon-Larsen P, Lavie CJ, Lear SA, Ndumele CE, Neeland IJ, Sanders P, St-Onge MP; American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Epidemiology and Prevention; and Stroke Council. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021 May 25;143(21):e984-e1010. doi: 10.1161/CIR.0000000000000973. Epub 2021 Apr 22.

    PubMed 33882682

  • Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473-83.

    PubMed 1593914

  • Gjestvang C, Abrahamsen F, Stensrud T, Haakstad LAH. Motives and barriers to initiation and sustained exercise adherence in a fitness club setting-A one-year follow-up study. Scand J Med Sci Sports. 2020 Sep;30(9):1796-1805. doi: 10.1111/sms.13736. Epub 2020 Jun 15.

    PubMed 32488898

  • Sallis JF, Grossman RM, Pinski RB, Patterson TL, Nader PR. The development of scales to measure social support for diet and exercise behaviors. Prev Med. 1987 Nov;16(6):825-36. doi: 10.1016/0091-7435(87)90022-3.

    PubMed 3432232

  • McClaran SR. The effectiveness of personal training on changing attitudes towards physical activity. J Sports Sci Med. 2003 Mar 1;2(1):10-4. eCollection 2003 Mar.

    PubMed 24616604

  • Sorensen M, Gill DL. Perceived barriers to physical activity across Norwegian adult age groups, gender and stages of change. Scand J Med Sci Sports. 2008 Oct;18(5):651-63. doi: 10.1111/j.1600-0838.2007.00686.x. Epub 2007 Dec 11.

    PubMed 18086263

  • Murcia JA, Gimeno EC, Camacho AM. Measuring self-determination motivation in a physical fitness setting: validation of the Behavioral Regulation in Exercise Questionnaire-2 (BREQ-2) in a Spanish sample. J Sports Med Phys Fitness. 2007 Sep;47(3):366-74.

    PubMed 17641607

  • Gron Jensen LC, Boie S, Axelsen S. International consultation on incontinence questionnaire - Urinary incontinence short form ICIQ-UI SF: Validation of its use in a Danish speaking population of municipal employees. PLoS One. 2022 Apr 6;17(4):e0266479. doi: 10.1371/journal.pone.0266479. eCollection 2022.

    PubMed 35385519

  • Moutao JM, Serra LF, Alves JA, Leitao JC, Vlachopoulos SP. Validation of the Basic Psychological Needs in Exercise Scale in a Portuguese sample. Span J Psychol. 2012 Mar;15(1):399-409. doi: 10.5209/rev_sjop.2012.v15.n1.37346.

    PubMed 22379729

  • Bringedal B, Aasland OG. [Doctors' use and assessment of a fee-for-service life-style advice scheme]. Tidsskr Nor Laegeforen. 2006 Apr 6;126(8):1036-8. Norwegian.

    PubMed 16619061

  • Brzycki M. Strength testing-predicting a one-rep max from reps-to-fatigue. Journal of Physical Education, Recreation & Dance. 1993;64(1):88-90.

  • Gjestvang C, Kalhovde JM, Mauseth Tangen E, Clemm H, Haakstad LAH. Impact of In-Person and Mobile Exercise Coaching on Psychosocial Factors Affecting Exercise Adherence in Inactive Women With Obesity: 20-Week Randomized Controlled Trial. J Med Internet Res. 2025 Feb 25;27:e68462. doi: 10.2196/68462.

    PubMed 39999434

Questions about this trial

What is this clinical trial studying?

A study testing High dosage in-person exercise coaching, Medium dosage in-person exercise coaching. and Low dosage in-person exercise coaching in people with Obesity, run by Norges idrettshøgskole at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 31 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Tron Krosshaug, PhD (+4745660046, Tronk@nih.no), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Adherence (attendance) to prescribed exercise sessions (time frame: Continuously during the intervention period of 20 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05792657, which also lists 15 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Mar 2023; AzTrials last refreshed its copy on 6 Nov 2026.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in